Home Others Others DIRECT RED 80

research use only

DIRECT RED 80

Cat.No.E2905

Direct Red 80 (Sirius Red) is a polyazo dye used principally in staining methods for collagen and amyloid. Direct Red 80 does not release benzidine upon degradation and is safer than many traditional direct dyes.
DIRECT RED 80 Chemical Structure

Chemical Structure

Molecular Weight: 1379.13

Jump to

Quality Control

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 1379.13 Formula

C45H32N10O21S6.6Na

 Storage (From the date of receipt) 3 years -20°C powder
CAS No. 2610-10-8 -- Storage of Stock Solutions

Read more about storage stability stock solution CAS number

Mechanism of Action

References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT05428410 Unknown status
Chronic Rhino-sinusitis|IL-4R|Monoclonal Antibody|Biomarker
Beijing Tongren Hospital
 2022-06-17 --
NCT05898191 Active not recruiting
Pelvic Floor Disorders|Vaginal Atrophy
Institute for the Care of Mother and Child Prague Czech Republic|Department of Obstetrics and Gynecology Faculty of Medicine CUNI Pilsen Czechia|NTIS Faculty of Applied Sciences University of West Bohemia Pilsen Czechia
 2019-02-01 Not Applicable
NCT03559465 Recruiting
Scleroderma Systemic
University Hospital Lille
 2018-10-29 Not Applicable
NCT02387151 Completed
Rejection|Graft Loss
Leiden University Medical Center
 2015-03 Phase 1
NCT02057965 Unknown status
Renal Transplant Rejection|Fibrosis
Leiden University Medical Center
 2014-03 Phase 2
NCT00734396 Completed
Organ Transplantation
Leiden University Medical Center
 2009-02 Phase 1|Phase 2

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.